Frazier Financial Advisors LLC Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Frazier Financial Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 617 shares of the healthcare conglomerate’s stock after selling 25 shares during the quarter. Frazier Financial Advisors LLC’s holdings in UnitedHealth Group were worth $361,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its stake in UnitedHealth Group by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after buying an additional 35,533 shares during the last quarter. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after buying an additional 21,149 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Barclays reduced their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Finally, UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $592.23 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $545.02 billion, a price-to-earnings ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The business has a 50 day simple moving average of $582.84 and a 200-day simple moving average of $549.52.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the business earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.